RUA Life Sciences plc Provides Revenue Guidance for the Year Ended 31 March 2024

RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.